Hormone Replacement Therapy Market Estimated to Reach US$ 11.5 Billion Globally By 2027

According to the recent report by IMARC Group, titled "Hormone Replacement Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," offers a comprehensive analysis of the industry, which comprises insights on hormone replacement therapy market. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global hormone replacement therapy market size reached US$ 8.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 11.5 Billion by 2027, exhibiting a growth rate (CAGR) of 6.1% during 2022-2027.

Hormones refer to chemical messengers that play an essential role in controlling fertility, mood and growth of the human body. Hormone replacement therapy (HRT) is utilized for replenishing the hormones that are present at low levels in the human body. This treatment is particularly favorable for patients experiencing growth hormone deficiency, women nearing menopause and older people suffering from hypogonadism. It is widely available in several forms, such as estrogen and testosterone gels, injections, skin patches and implants. It plays a significant role in reducing hot flashes, risk of osteoporosis, night sweats, pain, itching during intercourse and vaginal dryness.

Get a Free Sample Copy of this Report: https://www.imarcgroup.com/hormone-replacement-therapy-market/requestsample

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Global Hormone Replacement Therapy Market Trends:

One of the key factors driving the global market is the rising prevalence of hormone imbalance disorders among individuals. This is supported by the increasing number of patients suffering from hypogonadism across the globe. Along with this, continual technological innovations, such as the introduction of gel-based medications, are significantly supporting the global market. Moreover, the growing awareness among consumers and the presence of regularly monitored formulations are creating a positive market outlook. Other factors, including the escalating need for new treatment options with better safety results and growing investments by leading players in extensive research and development (R&D) activities to introduce improved formulations, are also positively influencing the market growth.

View Full Report with TOC & List of Figure: https://www.imarcgroup.com/hormone-replacement-therapy-market

Competitive Landscape with Key players:

The report has also analysed the competitive landscape of the market with some of the key players being.
• Abbott Laboratories
• Bayer AG
• Eli Lilly & Company
• Roche
• Hisamitsu Pharmaceutical Co. Inc.
• Merck
• Mylan
• Novartis
• Novo Nordisk
• Pfizer

Hormone Replacement Therapy Market Segmentation:

Our report has categorized the market based on region, product, route of administration and type of disease.

Breakup by Product:
• Estrogen Replacement Therapy
• Human Growth Hormone Replacement Therapy
• Thyroid Replacement Therapy
• Testosterone Replacement Therapy
• Others

Breakup by Route of Administration:
• Oral
• Parenteral
• Transdermal

Breakup by Type of Disease:
• Menopause
• Hypothyroidism
• Male Hypogonadism
• Growth Hormone Deficiency
• Others

Breakup by Region:
• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:
• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

We are updating our reports, If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.

Browse Other Reports:

https://www.digitaljournal.com/pr/veterinary-software-market-share-size-future-growth-trends-evaluation-regional-analysis-and-forecast-2021-2026

https://www.digitaljournal.com/pr/rotary-pump-market-expanding-at-a-cagr-of-5-39-during-2022-2027

https://www.digitaljournal.com/pr/rubber-processing-chemicals-market-estimated-to-reach-us-6-4-billion-globally-by-2027

https://www.digitaljournal.com/pr/telecom-electronic-manufacturing-services-ems-market-expanding-at-a-cagr-of-6-4-during-2022-2027

https://www.digitaljournal.com/pr/calcium-nitrate-market-size-industry-report-analysis-growth-future-trends-demand-and-forecast-2021-2026

Contact US:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.